Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Olfson, M.
* Articles by Weiden, P. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Olfson, M.
* Articles by Weiden, P. J.
Related Collections
* Treatment Compliance
* Schizophrenia Spectrum Disorders
Psychiatr Serv 51:216-222, February 2000
© 2000 American Psychiatric Association


Other Article

Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia

Mark Olfson, M.D., M.P.H., David Mechanic, Ph.D., Stephen Hansell, Ph.D., Carol A. Boyer, Ph.D., James Walkup, Ph.D. and Peter J. Weiden, M.D.

OBJECTIVE: The study sought to identify predictors of noncompliance with medication in a cohort of patients with schizophrenia after discharge from acute hospitalization. METHODS: Adult psychiatric inpatients with schizophrenia or schizoaffective disorder for whom oral antipsychotics were prescribed (N=213) were evaluated at hospital discharge and three months later to assess medication compliance. Comparisons were made between patients who reported stopping their medications for one week or longer and patients who reported more continuous medication use. RESULTS: Of the 213 patients, about a fifth (19.2 percent) met the criterion for noncompliance. Medication noncompliance was significantly associated with an increased risk of rehospitalization, emergency room visits, homelessness, and symptom exacerbation. Compared with the compliant group, the noncompliant group was significantly more likely to have a history of medication noncompliance, substance abuse or dependence, and difficulty recognizing their own symptoms. Patients who became medication noncompliant were significantly less likely to have formed a good therapeutic alliance during hospitalization as measured by inpatient staff reports and were more likely to have family members who refused to become involved in their treatment. CONCLUSIONS: Patients with schizophrenia at high risk for medication noncompliance after acute hospitalization are characterized by a history of medication noncompliance, recent substance use, difficulty recognizing their own symptoms, a weak alliance with inpatient staff, and family who refuse to become involved in inpatient treatment.




This article has been cited by other articles:


Home page
Schizophr BullHome page
R. Mojtabai, L. Fochtmann, S.-W. Chang, R. Kotov, T. J. Craig, and E. Bromet
Unmet Need for Mental Health Care in Schizophrenia: An Overview of Literature and New Data From a First-Admission Study
Schizophr Bull, July 1, 2009; 35(4): 679 - 695.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
E. P. Fischer, J. C. McSweeney, J. M. Pyne, D. K. Williams, A. J. Naylor, F. C. Blow, and R. R. Owen
Influence of Family Involvement and Substance Use on Sustained Utilization of Services for Schizophrenia
Psychiatr Serv, August 1, 2008; 59(8): 902 - 908.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
D. I. Velligan, P. M. Diamond, J. Mintz, N. Maples, X. Li, J. Zeber, L. Ereshefsky, Y.-W. F. Lam, D. Castillo, and A. L. Miller
The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia
Schizophr Bull, May 1, 2008; 34(3): 483 - 493.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. C. Marcus and M. Olfson
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Schizophr Bull, January 1, 2008; 34(1): 173 - 180.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. Olfson, S. C. Marcus, and H. Ascher-Svanum
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Schizophr Bull, November 1, 2007; 33(6): 1379 - 1387.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
A. C. Singh, A. J. Massey, M. D. Thompson, L. R. Rappa, and M. S. Honeywell
Addressing Nonadherence in the Schizophrenic Population
Journal of Pharmacy Practice, December 1, 2006; 19(6): 361 - 368.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
M. Linden, T. Scheel, and F.-X. Eich
Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride
J Psychopharmacol, November 1, 2006; 20(6): 815 - 823.
[Abstract] [PDF]


Home page
Schizophr BullHome page
D. I. Velligan, Y.-W. F. Lam, D. C. Glahn, J. A. Barrett, N. J. Maples, L. Ereshefsky, and A. L. Miller
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Schizophr Bull, October 1, 2006; 32(4): 724 - 742.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Pyne, J. McSweeney, H. S. Kane, S. Harvey, L. Bragg, and E. Fischer
Agreement Between Patients With Schizophrenia and Providers on Factors of Antipsychotic Medication Adherence
Psychiatr Serv, August 1, 2006; 57(8): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. T. Compton, B. E. Rudisch, J. Craw, T. Thompson, and D. A. Owens
Predictors of Missed First Appointments at Community Mental Health Centers After Psychiatric Hospitalization
Psychiatr Serv, April 1, 2006; 57(4): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. R. E. BARNES, S. H. MUTSATSA, S. B. HUTTON, H. C. WATT, and E. M. JOYCE
Comorbid substance use and age at onset of schizophrenia
The British Journal of Psychiatry, March 1, 2006; 188(3): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. Olfson, S. C. Marcus, J. Wilk, and J. C. West
Awareness of Illness and Nonadherence to Antipsychotic Medications Among Persons With Schizophrenia
Psychiatr Serv, February 1, 2006; 57(2): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. Medalia and R. Richardson
What Predicts a Good Response to Cognitive Remediation Interventions?
Schizophr Bull, October 1, 2005; 31(4): 942 - 953.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
J. E. Hovens, P. J. T. Dries, C. T. M. Melman, R. J. C. Wapenaar, and A. J. M. Loonen
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study
J Psychopharmacol, January 1, 2005; 19(1): 51 - 57.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
T. P. Gilmer, C. R. Dolder, J. P. Lacro, D. P. Folsom, L. Lindamer, P. Garcia, and D. V. Jeste
Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia
Am J Psychiatry, April 1, 2004; 161(4): 692 - 699.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
H. Rittmannsberger, T. Pachinger, P. Keppelmuller, and J. Wancata
Medication Adherence Among Psychotic Patients Before Admission to Inpatient Treatment
Psychiatr Serv, February 1, 2004; 55(2): 174 - 179.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. O'Donnell, G. Donohoe, L. Sharkey, N. Owens, M. Migone, R. Harries, A. Kinsella, C. Larkin, and E. O'Callaghan
Compliance therapy: a randomised controlled trial in schizophrenia
BMJ, October 11, 2003; 327(7419): 834.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
P. Thieda, S. Beard, A. Richter, and J. Kane
An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia
Psychiatr Serv, April 1, 2003; 54(4): 508 - 516.
[Abstract] [Full Text] [PDF]


Home page
West J Nurs ResHome page
Y. Kozuki and E. S. Froelicher
Lack of Awareness and Nonadherence in Schizophrenia
West J Nurs Res, February 1, 2003; 25(1): 57 - 74.
[Abstract] [PDF]


Home page
Psychosom. Med.Home page
C. R. Dolder, J. P. Lacro, and D. V. Jeste
Adherence to Antipsychotic and Nonpsychiatric Medications in Middle-Aged and Older Patients With Psychotic Disorders
Psychosom Med, January 1, 2003; 65(1): 156 - 162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. Zygmunt, M. Olfson, C. A. Boyer, and D. Mechanic
Interventions to Improve Medication Adherence in Schizophrenia
Am J Psychiatry, October 1, 2002; 159(10): 1653 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
N. C. Patel, P. G. Dorson, N. Edwards, S. Mendelson, and M. L. Crismon
One-Year Rehospitalization Rates of Patients Discharged on Atypical Versus Conventional Antipsychotics
Psychiatr Serv, July 1, 2002; 53(7): 891 - 893.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
S. Magura, A. B. Laudet, D. Mahmood, A. Rosenblum, and E. Knight
Adherence to Medication Regimens and Participation in Dual-Focus Self-Help Groups
Psychiatr Serv, March 1, 2002; 53(3): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C. R. Dolder, J. P. Lacro, L. B. Dunn, and D. V. Jeste
Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Am J Psychiatry, January 1, 2002; 159(1): 103 - 108.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org